Rosengarten, Marsha. 2004. Consumer activism in the pharmacology of HIV. Body & Society, 10(1), pp. 91-107. ISSN 1357034X [Article]

No full text available

Abstract or Description

This article explores problems posed by HIV anti-retroviral combination therapies by focusing on the UK media promotion of Trizivir (a GlaxoSmithKline three-drugs-in-one tablet). Using the substance of the figural in the style of feminist critiques of science and borrowing from actor network theory, a synergistic relationship comprising HIV, anti-HIV drugs, drug manufacturers and their media, medical publications, consumer representative treatment information and mass media is shown to construct a worrisome set of choices. The coming together of otherwise divergent interests and media raises questions about a certain adherence to drug manufacturer ‘facts’. But more provocative is the Trizivir campaign itself. For it suggests a stridency that goes well beyond the limits of its choices and, in doing so, offers the possibility for renewed consumer activism.

Item Type:	Article
Identification Number (DOI):	https://doi.org/10.1177/1357034X04041762
Keywords:	consumer activism, drug advertising, HIV anti-retroviral therapy, media
Departments, Centres and Research Units:	Sociology > Centre for Study of Invention and Social Process (CSISP) [2003-2015]
Dates:	Date Event 1 March 2004 Published
Item ID:	1944
Date Deposited:	12 Mar 2009 15:42
Last Modified:	07 Jul 2017 12:26
Peer Reviewed:	Yes, this version has been peer-reviewed.
URI:	https://research.gold.ac.uk/id/eprint/1944

Edit Record (login required)